2023 Q2 Form 10-Q Financial Statement

#000145247723000018 Filed on April 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $9.090M $9.347M $13.78M
YoY Change 21.23% -32.16% 588.51%
Cost Of Revenue $9.000M $8.766M $2.800M
YoY Change 121.13% 213.07% 291.61%
Gross Profit $8.020M $8.275M $12.71M
YoY Change 24.63% -34.91% 888.65%
Gross Profit Margin 88.23% 88.53% 92.28%
Selling, General & Admin $1.470M $796.0K $946.0K
YoY Change 6.68% -15.86% 59.8%
% of Gross Profit 18.33% 9.62% 7.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $3.130M $452.0K $1.506M
YoY Change 72.17% -69.99% 64.05%
Operating Profit $4.890M $7.823M $11.21M
YoY Change 5.91% -30.2% 2945.65%
Interest Expense $7.927M $7.694M $1.737M
YoY Change 163.62% 342.95%
% of Operating Profit 162.11% 98.35% 15.5%
Other Income/Expense, Net
YoY Change
Pretax Income $4.671M $7.823M $11.17M
YoY Change 1.17% -29.97% 2935.6%
Income Tax $27.00K $20.00K $45.00K
% Of Pretax Income 0.58% 0.26% 0.4%
Net Earnings $4.644M $7.803M $11.13M
YoY Change 1.44% -29.87% 3078.86%
Net Earnings / Revenue 51.09% 83.48% 80.76%
Basic Earnings Per Share $0.32 $0.53 $0.76
Diluted Earnings Per Share $0.32 $0.53 $0.76
COMMON SHARES
Basic Shares Outstanding 14.71M shares 14.71M shares 14.51M shares
Diluted Shares Outstanding 14.61M shares 14.58M shares 14.52M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.80M $84.30M $8.953M
YoY Change 69.6% 841.58% -80.89%
Cash & Equivalents $81.81M $84.30M $8.953M
Short-Term Investments
Other Short-Term Assets $1.500M $1.176M $3.353M
YoY Change -51.74% -64.93% 999.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $83.30M $85.48M $12.31M
YoY Change 62.26% 594.59% -73.9%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $622.7M
YoY Change 322.9%
Other Assets $200.0K $8.000K $9.000K
YoY Change 20.48% -11.11% -95.91%
Total Long-Term Assets $644.6M $621.3M $622.7M
YoY Change -3.84% -0.23% 320.98%
TOTAL ASSETS
Total Short-Term Assets $83.30M $85.48M $12.31M
Total Long-Term Assets $644.6M $621.3M $622.7M
Total Assets $727.9M $706.8M $635.0M
YoY Change 0.86% 11.3% 225.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.300M $3.262M $967.0K
YoY Change 261.04% 237.33% -13.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.400M $5.633M $2.093M
YoY Change 228.31% 169.14% 14.81%
LONG-TERM LIABILITIES
Long-Term Debt $452.7M $433.4M $367.7M
YoY Change 0.0% 17.87%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $452.7M $433.4M $367.7M
YoY Change 0.0% 17.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.400M $5.633M $2.093M
Total Long-Term Liabilities $452.7M $433.4M $367.7M
Total Liabilities $460.1M $439.0M $369.8M
YoY Change 1.13% 18.73% 20183.71%
SHAREHOLDERS EQUITY
Retained Earnings $58.14M $53.50M $35.78M
YoY Change 44.08% 49.54% 10121.71%
Common Stock $239.2M $238.6M $237.7M
YoY Change 0.38% 0.38% 23.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $267.8M $267.7M $265.3M
YoY Change
Total Liabilities & Shareholders Equity $727.9M $706.8M $635.0M
YoY Change 0.86% 11.3% 225.54%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $4.644M $7.803M $11.13M
YoY Change 1.44% -29.87% 3078.86%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $5.030M $6.577M $3.085M
YoY Change 56.11% 113.19% -322.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$21.09M $50.27M -$44.61M
YoY Change -53.03% -212.68% -18.95%
Cash From Investing Activities -$21.09M $50.27M -$44.61M
YoY Change -53.03% -212.68% -18.95%
FINANCING ACTIVITIES
Cash Dividend Paid $5.147M $3.649M
YoY Change 41.05%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.79M -$43.60M $24.19M
YoY Change -83.0% -280.22% -31934.21%
NET CHANGE
Cash From Operating Activities 5.030M $6.577M $3.085M
Cash From Investing Activities -21.09M $50.27M -$44.61M
Cash From Financing Activities 13.79M -$43.60M $24.19M
Net Change In Cash -2.270M $13.24M -$17.33M
YoY Change -105.76% -176.39% -69.32%
FREE CASH FLOW
Cash From Operating Activities $5.030M $6.577M $3.085M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
255 Washington Street
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001452477
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34383
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Seven Hills Realty Trust
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4649929
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Two Newton Place
CY2023Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 300
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Newton
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02458-1634
CY2023Q1 dei City Area Code
CityAreaCode
617
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
332-9530
CY2023Q1 dei Security12b Title
Security12bTitle
Common Shares of Beneficial Interest
CY2023Q1 dei Trading Symbol
TradingSymbol
SEVN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14706862 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84300000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71057000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
8000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
10000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
622070000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
669929000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
4135000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
617935000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
669929000 usd
CY2023Q1 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
3346000 usd
CY2022Q4 us-gaap Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
3354000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1176000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2497000 usd
CY2023Q1 us-gaap Assets
Assets
706765000 usd
CY2022Q4 us-gaap Assets
Assets
746847000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3262000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1903000 usd
CY2023Q1 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
433385000 usd
CY2022Q4 us-gaap Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
471521000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
2371000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1844000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
439018000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
475268000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14706862 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14706862 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14709165 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14709165 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
15000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
238612000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
238505000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53498000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
52290000 usd
CY2023Q1 us-gaap Cumulative Dividends
CumulativeDividends
24378000 usd
CY2022Q4 us-gaap Cumulative Dividends
CumulativeDividends
19231000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
267747000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
271579000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
706765000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
746847000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
15856000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
9579000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1185000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5935000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7694000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
1737000 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
9347000 usd
CY2022Q1 us-gaap Net Investment Income
NetInvestmentIncome
13777000 usd
CY2023Q1 sevn Base Management Fee
BaseManagementFee
1072000 usd
CY2022Q1 sevn Base Management Fee
BaseManagementFee
1063000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
796000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
872000 usd
CY2023Q1 sevn Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
643000 usd
CY2022Q1 sevn Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
634000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-987000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2023Q1 sevn Other Transaction Related Costs
OtherTransactionRelatedCosts
0 usd
CY2022Q1 sevn Other Transaction Related Costs
OtherTransactionRelatedCosts
37000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1524000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
2606000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7823000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11171000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7803000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11126000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14582000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14505000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14582000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14519000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
271579000 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
121000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
1000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7803000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5147000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
267747000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
257694000 usd
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
82000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11126000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3649000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
265253000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7803000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11126000 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1185000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5935000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-987000 usd
CY2022Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
0 usd
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
1004000 usd
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
1298000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
307000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
209000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
120000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
82000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-8000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
133000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1101000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
387000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-113000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-594000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-527000 usd
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-15000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6577000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3085000 usd
CY2023Q1 sevn Payments For Originations Of Mortgage Loans Held For Investments
PaymentsForOriginationsOfMortgageLoansHeldForInvestments
0 usd
CY2022Q1 sevn Payments For Originations Of Mortgage Loans Held For Investments
PaymentsForOriginationsOfMortgageLoansHeldForInvestments
90036000 usd
CY2023Q1 sevn Payments For Additional Originations Of Mortgage Loans Held For Investments
PaymentsForAdditionalOriginationsOfMortgageLoansHeldForInvestments
1651000 usd
CY2022Q1 sevn Payments For Additional Originations Of Mortgage Loans Held For Investments
PaymentsForAdditionalOriginationsOfMortgageLoansHeldForInvestments
3219000 usd
CY2023Q1 sevn Repayment Of Loan Held For Investment
RepaymentOfLoanHeldForInvestment
51918000 usd
CY2022Q1 sevn Repayment Of Loan Held For Investment
RepaymentOfLoanHeldForInvestment
48643000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50267000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44612000 usd
CY2023Q1 sevn Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
0 usd
CY2022Q1 sevn Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
130160000 usd
CY2023Q1 sevn Repayments For Securities Sold Under Agreements To Repurchase
RepaymentsForSecuritiesSoldUnderAgreementsToRepurchase
38125000 usd
CY2022Q1 sevn Repayments For Securities Sold Under Agreements To Repurchase
RepaymentsForSecuritiesSoldUnderAgreementsToRepurchase
101597000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
318000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
720000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5147000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
3649000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43603000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24194000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13241000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17333000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71067000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26295000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84308000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8962000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
7408000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1584000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
47000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84300000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8953000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
8000 usd
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
9000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84308000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8962000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in the accompanying condensed consolidated financial statements include the allowance for credit losses and the fair value of financial instruments.
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior year amounts have been reclassified to conform to current year presentation.
CY2023Q1 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
25 loan
CY2022 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
27 loan
CY2023Q1 sevn Loans Held For Investment Commitments
LoansHeldForInvestmentCommitments
674475000 usd
CY2022Q4 sevn Loans Held For Investment Commitments
LoansHeldForInvestmentCommitments
727562000 usd
CY2023Q1 sevn Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
45779000 usd
CY2022Q4 sevn Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
49007000 usd
CY2023Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
628696000 usd
CY2022Q4 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
678555000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
617935000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
669929000 usd
CY2023Q1 sevn Loans Receivable Weighted Average Coupon Rate Percentage
LoansReceivableWeightedAverageCouponRatePercentage
0.0857
CY2022Q4 sevn Loans Receivable Weighted Average Coupon Rate Percentage
LoansReceivableWeightedAverageCouponRatePercentage
0.0807
CY2023Q1 sevn Loans Receivable Average All In Yield Percentage
LoansReceivableAverageAllInYieldPercentage
0.0906
CY2022Q4 sevn Loans Receivable Average All In Yield Percentage
LoansReceivableAverageAllInYieldPercentage
0.0857
CY2023Q1 sevn Loans Receivable Weighted Average Libor Floor Percentage
LoansReceivableWeightedAverageLIBORFloorPercentage
0.0065
CY2022Q4 sevn Loans Receivable Weighted Average Libor Floor Percentage
LoansReceivableWeightedAverageLIBORFloorPercentage
0.0062
CY2023Q1 sevn Loans Receivable Weighted Average Term Of Maturity
LoansReceivableWeightedAverageTermOfMaturity
P3Y1M6D
CY2022 sevn Loans Receivable Weighted Average Term Of Maturity
LoansReceivableWeightedAverageTermOfMaturity
P3Y3M18D
CY2023Q1 sevn Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
2.9
CY2022Q4 sevn Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
2.9
CY2022Q4 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
678555000 usd
CY2022Q4 sevn Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
8626000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
669929000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
1884000 usd
CY2023Q1 sevn Mortgage Loan Additional Funding Deferred Fees And Other Items
MortgageLoanAdditionalFundingDeferredFeesAndOtherItems
-14000 usd
CY2023Q1 sevn Mortgage Loan Additional Funding Net
MortgageLoanAdditionalFundingNet
1870000 usd
CY2023Q1 sevn Mortgage Loan Repayments Gross
MortgageLoanRepaymentsGross
51743000 usd
CY2023Q1 sevn Mortgage Loan Repayments Deferred Fees And Other Items
MortgageLoanRepaymentsDeferredFeesAndOtherItems
175000 usd
CY2023Q1 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
51918000 usd
CY2023Q1 sevn Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
1004000 usd
CY2023Q1 sevn Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
1004000 usd
CY2023Q1 sevn Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
1185000 usd
CY2023Q1 sevn Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
1185000 usd
CY2023Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
628696000 usd
CY2023Q1 sevn Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
6626000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
622070000 usd
CY2021Q4 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
590590000 usd
CY2021Q4 sevn Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
19810000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
570780000 usd
CY2022Q1 us-gaap Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
3304000 usd
CY2022Q1 sevn Mortgage Loan Additional Funding Net
MortgageLoanAdditionalFundingNet
3304000 usd
CY2022Q1 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
91184000 usd
CY2022Q1 us-gaap Mortgage Loans On Real Estate Other Deductions
MortgageLoansOnRealEstateOtherDeductions
1148000 usd
CY2022Q1 us-gaap Mortgage Loans On Real Estate Period Increase Decrease
MortgageLoansOnRealEstatePeriodIncreaseDecrease
90036000 usd
CY2022Q1 sevn Mortgage Loan Repayments Gross
MortgageLoanRepaymentsGross
48247000 usd
CY2022Q1 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
48247000 usd
CY2022Q1 sevn Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
902000 usd
CY2022Q1 sevn Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
902000 usd
CY2022Q1 sevn Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
5935000 usd
CY2022Q1 sevn Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
5935000 usd
CY2022Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
636831000 usd
CY2022Q1 sevn Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
14121000 usd
CY2022Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
622710000 usd
CY2023Q1 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
25 loan
CY2023Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
622070000 usd
CY2023Q1 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2022 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
27 loan
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
669929000 usd
CY2022Q4 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2023Q1 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
25 loan
CY2023Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
622070000 usd
CY2023Q1 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2022 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
27 loan
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
669929000 usd
CY2022Q4 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2023Q1 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
25 loan
CY2023Q1 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
0 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
207168000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
308164000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
106738000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
622070000 usd
CY2022 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
27 loan
CY2022Q4 sevn Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
1
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
206022000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
340818000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
78448000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
44641000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
669929000 usd
CY2022Q4 sevn Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
2.9
CY2023Q1 sevn Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
2.9
CY2023Q1 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
435490000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14582000 shares
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1503 shares
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
13000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.35
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.35
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5147000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14505000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 dei Entity Number Of Employees
EntityNumberOfEmployees
0 employee
CY2023Q1 sevn Base Management Fee Percent Fee Quarterly
BaseManagementFeePercentFeeQuarterly
0.00375
CY2023Q1 sevn Base Management Fee Percent Fee Annualized
BaseManagementFeePercentFeeAnnualized
0.015
CY2023Q1 sevn Base Management Fee
BaseManagementFee
1072000 usd
CY2022Q1 sevn Base Management Fee
BaseManagementFee
1063000 usd
CY2022Q1 sevn Management Incentive Fee
ManagementIncentiveFee
0 usd
CY2023Q1 sevn Management Incentive Fee
ManagementIncentiveFee
0 usd
CY2023Q1 sevn Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
643000 usd
CY2022Q1 sevn Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
634000 usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
14000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14582000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7803000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11126000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
67000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
70000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7736000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7736000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11056000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
11056000 usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14519000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2023Q1 sevn Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
45779000 usd

Files In Submission

Name View Source Status
0001452477-23-000018-index-headers.html Edgar Link pending
0001452477-23-000018-index.html Edgar Link pending
0001452477-23-000018.txt Edgar Link pending
0001452477-23-000018-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sevn-20230331.htm Edgar Link pending
sevn-20230331.xsd Edgar Link pending
sevn_033123xexhibitx311.htm Edgar Link pending
sevn_033123xexhibitx312.htm Edgar Link pending
sevn_033123xexhibitx313.htm Edgar Link pending
sevn_033123xexhibitx314.htm Edgar Link pending
sevn_033123xexhibitx321.htm Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
sevn-20230331_def.xml Edgar Link unprocessable
sevn-20230331_cal.xml Edgar Link unprocessable
sevn-20230331_pre.xml Edgar Link unprocessable
sevn-20230331_htm.xml Edgar Link completed
sevn-20230331_lab.xml Edgar Link unprocessable